181225-00-3

Upstream product

• 181224-95-3 (2R,3R,4S,4aR,11bR)-2-Hydroxy-5-(4-methoxy-benzyl)-3,4-bis-methoxymethoxy-1,3,4,4a,5,11b-hexahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-6-one 
• 137423-23-5 (2R,3R,4S,4aR)-5-(4-Methoxybenzyl)-2-<(4-methoxybenzyl)oxy>-3,4-bis<(methoxymethyl)oxy>-3,4,4a,5-tetrahydro<1,3>dioxolo<4,5-j>phenanthridin-6(2H)-one 
• 127-08-2 potassium acetate 
• 181224-98-6 Trifluoro-methanesulfonic acid (2R,3S,4S,4aR,11bR)-5-(4-methoxy-benzyl)-3,4-bis-methoxymethoxy-6-oxo-1,2,3,4,4a,5,6,11b-octahydro-[1,3]dioxolo[4,5-j]phenanthridin-2-yl ester 

Downstream Products

• 181225-08-1 (3R,4S,4aR,11bR)-5-(4-Methoxy-benzyl)-3,4-bis-methoxymethoxy-3,4a,5,11b-tetrahydro-4H-[1,3]dioxolo[4,5-j]phenanthridin-6-one 
• 181378-99-4 Trifluoro-methanesulfonic acid (2S,3S,4S,4aR,11bR)-5-(4-methoxy-benzyl)-3,4-bis-methoxymethoxy-6-oxo-1,2,3,4,4a,5,6,11b-octahydro-[1,3]dioxolo[4,5-j]phenanthridin-2-yl ester 
• 181225-16-1 Acetic acid (1R,2S,3S,4S,4aR,11bR)-2,3,4-triacetoxy-5-(4-methoxy-benzyl)-6-oxo-1,2,3,4,4a,5,6,11b-octahydro-[1,3]dioxolo[4,5-j]phenanthridin-1-yl ester 
• 181225-02-5 Acetic acid (2S,3R,4S,4aR,11bR)-2,3-diacetoxy-5-(4-methoxy-benzyl)-6-oxo-1,2,3,4,4a,5,6,11b-octahydro-[1,3]dioxolo[4,5-j]phenanthridin-4-yl ester 
• 181225-14-9 C₂₂H₂₁NO₇ 
• 181225-12-7 (3R,4S,4aR,11bR)-3,4-Dihydroxy-5-(4-methoxy-benzyl)-3,4a,5,11b-tetrahydro-4H-[1,3]dioxolo[4,5-j]phenanthridin-6-one 
• 181378-98-3 (2S,3R,4S,4aR,11bR)-2-Hydroxy-5-(4-methoxy-benzyl)-3,4-bis-methoxymethoxy-1,3,4,4a,5,11b-hexahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-6-one 

Relevant academic research and scientific papers

Total synthesis of (+)-7-deoxypancratistatin and (+)-7-deoxy-trans-dihydronarciclasine

The chiral and stereoselective synthesis of antimitotic phenanthridone alkaloids, (+)-7-deoxypancratistatin (1) and (+)-7-deoxy- trans-dihydronarciclasine (2) is described. Both natural products were synthesized from the common compound (4), which had been prepared from D-glucose and employed for the synthesis of lycoricidine (3).